Combination effects of distinct cores in 11q13 amplification region on cervical lymph node metastasis of oral squamous cell carcinoma

International Journal of Oncology

Volumn 39, Issue 4, 2011, Pages 761-769

  Sugahara, Keisuke ^a,b   Michikawa, Yuichi ^a   Ishikawa, Kenichi ^a   Shoji, Yoshimi ^a   Iwakawa, Mayumi ^a   Shibahara, Takahiko ^b   Imai, Takashi ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

Author keywords

11q13; ArrayCGH; Copy number abnormality; Lymph node metastasis; Squamous cell carcinoma

Indexed keywords

FAS ASSOCIATED DEATH DOMAIN PROTEIN; FIBROBLAST GROWTH FACTOR 4;

ADULT; AGED; ARTICLE; CCND1 GENE; CERVICAL LYMPH NODE; CHROMOSOME 11Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; CTTN GENE; DHCR7 GENE; FADD GENE; FEMALE; GENE AMPLIFICATION; HEREDITY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MYEOV GENE; NUCLEOTIDE SEQUENCE; ONCOGENE; ORAOV1 GENE; OVERALL SURVIVAL; PPF1A1 GENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SHANK2 GENE; SQUAMOUS CELL CARCINOMA; TMEM16A GENE; TPCN2 GENE;

CALCIUM CHANNELS; CARCINOMA, SQUAMOUS CELL; CERVIX UTERI; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; COMPARATIVE GENOMIC HYBRIDIZATION; CORTACTIN; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTO-ONCOGENE PROTEINS;

EID: 79960864501     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1094     Document Type: Article

References (38)

1. Sudbo J: Novel management of oral cancer: a paradigm of predictive oncology. Clin Med Res 2: 233-242, 2004.
2. Casiglia J and Woo SB: A comprehensive review of oral cancer. Gen Dent 49: 72-82, 2001.
3. Leemans CR, Tiwari R, Nauta JJ, van der Waal I and Snow GB: Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 71: 452-456, 1993. (Pubitemid 23021234)
4. Leemans CR, Tiwari R, Nauta JJ, van der Waal I and Snow GB: Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer 73: 187-190, 1994. (Pubitemid 24012742)
5. Greenberg JS, Fowler R, Gomez J, et al: Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. Cancer 97: 1464-1470, 2003. (Pubitemid 36297776)
6. Ng SH, Yen TC, Liao CT, et al: 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med 46: 1136-1143, 2005.
7. Sun R, Zhang JG and Guo CB: Establishment of cervical lymph node metastasis model of squamous cell carcinoma in the oral cavity in mice. Chin Med J 121: 1891-1895, 2008.
8. Martin CL, Reshmi SC, Ried T, et al: Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature. Oral Oncol 44: 369-382, 2008. (Pubitemid 351380982)
9. Bockmuhl U, Petersen S, Schmidt S, et al: Patterns of chromosomal alterations in metastasizing and nonmetastasizing primary head and neck carcinomas. Cancer Res 57: 5213-5216, 1997. (Pubitemid 27516350)
10. Suzuki E, Imoto I, Pimkhaokham A, et al: PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation. Oncogene 26: 7921-7932, 2007. (Pubitemid 350261784)
11. Liu CJ, Lin SC, Chen YJ, Chang KM and Chang KW: Array-comparative genomic hybridization to detect genomewide changes in microdissected primary and metastatic oral squamous cell carcinomas. Mol Carcinog 45: 721-731, 2006.
12. Barrett MT, Scheffer A, Ben-Dor A, et al: Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA. Proc Natl Acad Sci USA 101: 17765-17770, 2004. (Pubitemid 40051961)
13. Xu C, Liu Y, Wang P, et al: Integrative analysis of DNA copy number and gene expression in metastatic oral squamous cell carcinoma identifies genes associated with poor survival. Mol Cancer 9: 143-148, 2010.
14. UICC: TNM classification of malignant tumours. 5h edition. pp20-24, 1997.
15. Weksberg R, Hughes S, Moldovan L, Bassett AS, Chow EW and Squire JA: A method for accurate detection of genomic micro-deletions using real-time quantitative PCR. BMC Genomics 6: 180-189, 2005.
16. Gotoh T, Hosoi H, Iehara T, et al: Prediction of MYCN ampli-fication in neuroblastoma using serum DNA and real-time quantitative polymerase chain reaction. J Clin Oncol 23: 5205-5210, 2005. (Pubitemid 46224030)
17. Huang Q, Yu GP, McCormick SA, et al: Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer 34: 224-233, 2002. (Pubitemid 34578679)
18. Lin SC, Chen YJ, Kao SY, et al: Chromosomal changes in betel-associated oral squamous cell carcinomas and their relationship to clinical parameters. Oral Oncol 38: 266-273, 2002.
19. Baldwin C, Garnis C, Zhang L, Rosin MP and Lam WL: Multiple microalterations detected at high frequency in oral cancer. Cancer Res 65: 7561-7567, 2005. (Pubitemid 41297225)
20. Sparano A, Quesnelle KM, Kumar MS, et al: Genome-wide profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization. Laryngoscope 116: 735-741, 2006. (Pubitemid 44318029)
21. Li Y, Tondravi M, Liu J, et al: Cortactin potentiates bone metastasis of breast cancer cells. Cancer Res 61: 6906-6911, 2001. (Pubitemid 32896517)
22. Komatsu Y, Hibi K, Kodera Y, Akiyama S, Ito K and Nakao A: TAOS1, a novel marker for advanced esophageal squamous cell carcinoma. Anticancer Res 26: 2029-2032, 2006. (Pubitemid 43989465)
23. Luo ML, Shen XM, Zhang Y, et al: Amplification and over-expression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. Cancer Res 66: 11690-11699, 2006. (Pubitemid 46094181)
24. Chen YJ, Lin SC, Kao T, et al: Genome-wide profiling of oral squamous cell carcinoma. J Pathol 204: 326-332, 2004. (Pubitemid 39430093)
25. Gollin SM: Chromosomal alterations in squamous cell carcinoma of the head and neck: window to the biology of disease. Head Neck 23: 238-253, 2001.
26. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E and Balm A: Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 55: 975-978, 1995.
27. Akervall JA, Michalides RJ, Mineta H, et al: Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer 79: 380-389, 1997. (Pubitemid 27029903)
28. Coquelle A, Pipiras E, Toledo F, Buttin G and Debatisse M: Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89: 215-225, 1997. (Pubitemid 27199894)
29. Debatisse M, Coquelle A, Toledo F and Buttin G: Gene ampli-fication mechanisms: the role of fragile sites. Recent Results Cancer Res 154: 216-226, 1998.
30. Ciullo M, Debily MA, Rozier L, et al: Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: the model of PIP gene duplication from a break at FRA7I. Hum Mol Genet 11: 2887-2894, 2002.
31. Reshmi SC, Roychoudhury S, Yu Z, et al: Inverted duplication pattern in anaphase bridges confirms the breakage-fusion-bridge (BFB) cycle model for 11q13 amplification. Cytogenet Genome Res 116: 46-52, 2007. (Pubitemid 46197129)
32. Weed SA and Parsons JT: Cortactin: coupling membrane dynamics to cortical actin assembly. Oncogene 20: 6418-6434, 2001. (Pubitemid 32977848)
33. Daly RJ: Cortactin signalling and dynamic actin networks. Biochem J 382: 13-25, 2004.
34. Rothschild BL, Shim AH, Ammer AG, et al: Cortactin over-expression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification. Cancer Res 66: 8017-8025, 2006. (Pubitemid 44299166)
35. Huang X, Godfrey TE, Gooding WE, McCarty KS Jr and Gollin SM: Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma. Genes Chromosomes Cancer 45: 1058-1069, 2006. (Pubitemid 44435540)
36. Xia J, Chen Q, Li B and Zeng X: Amplifications of TAOS1 and EMS1 genes in oral carcinogenesis: association with clinico-pathological features. Oral Oncol 43: 508-514, 2007. (Pubitemid 46561436)
37. Tomioka H, Morita K, Hasegawa S and Omura K. Gene expression analysis by cDNA microarray in oral squamous cell carcinoma. J Oral Pathol Med 35: 206-211, 2006. (Pubitemid 43362951)
38. Chen G, Bhojani MS, Heaford AC, et al: Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas. Proc Natl Acad Sci USA 102: 12507-12512, 2005. (Pubitemid 41266389)